Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

British Journal of Haematology · 2003 · 2.3K citations · Full text

Medicine, Hematology, Pathology +8

A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance

Robert A. Kyle, Terry M. Therneau, S. Vincent Rajkumar et al. · New England Journal of Medicine · 2002 · 1.5K citations

Medicine, Oncology, Pathology +13

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

Ola Landgren, Robert A. Kyle, Ruth M. Pfeiffer et al. · Blood · 2009 · 1.1K citations · Full text

Medicine, Hematology, Oncology +8

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

Robert A. Kyle, Ellen D. Remstein, Terry M. Therneau et al. · New England Journal of Medicine · 2007 · 919 citations · Full text

Medicine, Hematology, Pathology +17

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

PubMed · 2003 · 793 citations

Medicine, Hematology, Pathology +13